Onto Innovation Inc. — Form 10-Q Summary
Reporting period: Fiscal first quarter ended March 27, 2021; comparative quarter ended March 28, 2020. The filing is for 2019 Q1 per request metadata only if that was intended, the supplied filing itself clearly reports 2021 Q1.
Business context: Onto designs, manufactures, and supports process-control equipment and software for semiconductor and advanced-packaging manufacturers. It reports one operating segment. Results are unaudited and in thousands of dollars unless otherwise noted.
Key financial metrics
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $169.3 million | $139.9 million |
| Gross profit / margin | $90.5 million / 53.4% | $62.6 million / 44.8% |
| Operating income (loss) | $27.5 million | $(5.2) million |
| Net income (loss) | $24.1 million | $(4.4) million |
| Diluted EPS | $0.49 | $(0.09) |
| Cash from operating activities | $51.0 million | $8.9 million |
- Revenue increased 21% year over year. Systems and software contributed $141.5 million (84% of revenue), parts $17.4 million, and services $10.4 million.
- Gross margin rose to 53.4% from 44.8%. Management attributes the improvement primarily to the prior-year $9.9 million merger-related inventory fair-value charge and stronger product margins.
- Research and development expense was $22.0 million; sales and marketing $13.1 million; general and administrative $15.6 million; and intangible amortization $12.4 million.
- Cash, cash equivalents, and marketable securities totaled $392.9 million at quarter-end, up from $373.7 million at December 26, 2020. Working capital was $628.4 million.
- Total liabilities were $211.4 million. The filing reports no borrowings; an $82.0 million securities-backed credit line was available at a stated 1.8% rate and had not been used.
Material changes and notable items
- Revenue rose 9% sequentially from the December 2020 quarter, mainly on increased foundry sales for advanced-node applications. Year-over-year systems and software growth reflected more metrology and inspection units shipped.
- Operating cash flow increased to $51.0 million. Investing activities used $60.3 million, including $26.8 million for the Inspectrology acquisition and $3.9 million in capital expenditures; financing activities provided $0.6 million.
- Onto acquired Inspectrology on December 31, 2020, for $27.0 million cash, with a potential $10.0 million earnout tied to revenue targets and continued service by principals.
- Samsung Semiconductor represented 25% of revenue, TSMC 13%, and SK Hynix 12%; the prior-year figures were 18%, 17%, and less than 10%, respectively. South Korea generated $50.5 million of revenue, the largest geographic share.
- The company had $100 million remaining under its share-repurchase authorization at quarter-end. No program repurchases were reported for the quarter; 41,000 shares were withheld for employee tax obligations.
Outlook, risks, and contingencies
- No specific numerical revenue or earnings guidance is provided. Management expects existing cash, marketable securities, and available credit to cover anticipated needs for the next 12 months.
- Management reported no material direct financial impact from COVID-19 through the filing date, but warned that future effects remain uncertain, including possible demand, supply-chain, operating, and financing impacts.
- U.S. export restrictions affected approximately $25 million of China customer purchase orders; Onto had applied for licenses and was awaiting a response. Further restrictions could affect China sales.
- Key risks include customer and semiconductor-industry concentration, cyclical demand, export controls and trade tensions, component supply constraints, inventory forecasting, product development and competition, and integration of acquired and merged businesses.
- In the OSI litigation, discovery was ongoing. The company described the loss contingency as remote and did not expect a material financial impact. It also disclosed customary intellectual-property indemnification obligations for which a maximum exposure could not be reasonably estimated; no amount was accrued.
- COVID-19 had no material impact on the quarter’s reported financial statements, but management cautioned that future effects could be material. Disclosure controls were assessed as effective as of March 27, 2021.
Most important facts for investors to verify
- Confirm the intended reporting period: the supplied filing is Q1 2021, despite the request metadata stating 2019 Q1.
- Track whether the $25 million of China orders receive required export licenses and can be shipped.
- Monitor revenue dependence on major semiconductor customers and geographic concentration, particularly Samsung and South Korea.
- Assess whether gross-margin improvement persists without the prior-year merger-related inventory charge and with inventory provisions and mix changes.
- Review Inspectrology earnout conditions, integration progress, and the company’s acquisition-related costs and commitments.